Skip to main navigation Skip to search Skip to main content

(129) results of a First-in-Human Trial of LIB-01, a Novel, First in Class Potential Oral ED Drug with Unique Parmacodynamic Properties

Research output: Contribution to journalAbstractpeer-review

Original languageAmerican English
JournalJournal of Sexual Medicine
Volume21
Issue numberIssue Supplement 7
DOIs
StatePublished - Dec 2024
EventAnnual Meeting of the Sexual Medicine Society of North America - Scottsdale, United States
Duration: Oct 17 2024Oct 20 2024
Conference number: 25th

Funding

Yes, this is sponsored by industry/sponsor: Dicot Pharma AB. Clarification: Industry initiated, executed and funded study. Any of the authors act as a consultant, employee or shareholder of an industry for: Dicot Pharma AB.

Cite this